NL-OMON47750已完成4 期
A randomized trial of the effect of antiplatelet therapy (Aspirin, Aspirin and Clopidogrel or Ticagrelor) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty. - ASCOT trial
niversitair Medisch Centrum Utrecht0 个研究点目标入组 1,806 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,806
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •All patients of 18 and over with: (1) lesions to the iliac,
- •femoropopliteal or below the knee (BTK) arteries; (2) eligibility of lesions
- •for percutaneous transluminal angioplasty (PTA) or recanalization with or
- •without additional stenting (ST), (3) all TASC lesions [16]; (4) all Rutherford
- •(1-6) classes.
排除标准
- •Exclusion criteria are acute ischemia, PAD due to aneurysm abdominal or
- •popliteal, patients with reported intolerance or hypersensitivity for the study
- •medications, impossibility of discontinuing current antiplatelet therapy, the
- •use of anticoagulant therapy (coumarin derivatives; acenocoumarol /fenprocoumon
- •/warfarin), the use of non-steroidal anti-inflammatory drugs in the two weeks
- •prior to the venepuncture to determine eventual aspirin resistance, a history
- •of platelet/bleeding abnormalities, a platelet count < 100x*10^6/dl and
- •patients with a life expectancy less than one year.
研究者
相似试验
进行中（未招募）
1 期
The effect of antiplatelet therapy after angioplasty.EUCTR2016-002086-54-NLniversity Medical Center Utrecht1,806
尚未招募
不适用
A randomized trial of the effect of antiplatelet therapy (Aspirin, Aspirin and Clopidogrel or Ticagrelor) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty.antiplatelet therapy, peripheral transluminal angioplastyNL-OMON28759Antonius Hospital Nieuwegein, Medisch Centrum Alkmaar.1,252
进行中（未招募）
不适用
A pilot study investigating the antiplatelet effect of generic clopidogrel versus Plavix™ – is there any difference in platelet reactivity in healthy subjects? - The effect of Plavix versus generic clopidogrel on platelet reactivityThe intended indication for the product is for use in all patients with acute coronary syndromes and following coronary artery stentingEUCTR2010-022461-10-GBSouthampton University Hospitals NHS Trust15
招募中
4 期
A randomized clinical trial of an antiplatelet agent in the treatment of acute stroke: cilostazol in the prevention of acute progressing stroke (CAPS) studyCerebral infarctionJPRN-UMIN000001630Tohoku Acute Progressing Stroke Study Group500
已完成
不适用
Study on Therapeutic Effects of Antiplatelet Drugs in Prevention of Occurrence and Inhibition of Progression of Diabetic AtherosclerosisDiabetesJPRN-C000000215DAPC Study Steering Committee400